ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

No reading has been made of this study yet; what is shown is how the rules link it today.

4 links0 made here, not in the record4 judgments1 judge (the rules as one: Rule based)19 record changes seen
Rule basedRecord updated on ClinicalTrials.gov
Sep 28Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16TodayNCT06337318Comparing Rituximab andMosunetuzumab DrugTreatments for People WithLow Tumor Burden FollicularLymphomaNational Cancer Institute (NCIPhase 3 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Sep 29 · ClinicalTrials.gov record · Version of 2026-09-29Oct 1 · ClinicalTrials.gov record · Version of 2026-10-01Oct 5 · ClinicalTrials.gov record · Version of 2026-10-05Oct 6 · ClinicalTrials.gov record · Version of 2026-10-06Oct 7 · ClinicalTrials.gov record · Version of 2026-10-07Oct 8 · ClinicalTrials.gov record · Version of 2026-10-08Oct 9 · ClinicalTrials.gov record · Version of 2026-10-09Oct 13 · ClinicalTrials.gov record · Version of 2026-10-13Oct 14 · ClinicalTrials.gov record · Version of 2026-10-14Oct 20 · ClinicalTrials.gov record · Version of 2026-10-20Oct 21 · ClinicalTrials.gov record · Version of 2026-10-21Oct 23 · ClinicalTrials.gov record · Version of 2026-10-23Oct 26 · ClinicalTrials.gov record · Version of 2026-10-26Oct 28 · ClinicalTrials.gov record · Version of 2026-10-28Oct 29 · ClinicalTrials.gov record · Version of 2026-10-29Nov 3 · ClinicalTrials.gov record · Version of 2026-11-03Nov 9 · ClinicalTrials.gov record · Version of 2026-11-09Nov 12 · ClinicalTrials.gov record · Version of 2026-11-12Nov 18 · ClinicalTrials.gov record · Version of 2026-11-18Version of 2026-11-18CONDITIONSLymphoma, FollicularNo longer in the registry's filing›As of now · Rule based · Main conditionMain conditionDRUGSMosunetuzumabIntervention entry›As of now · Rule based · TestedTestedRituximabIntervention entry›As of now · Rule based · TestedTestedRituximab and Hyaluronidase…Intervention entry›As of now · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

Lymphoma, Follicular

From the registry record1 judgment on this link
Main condition (R9), from the registry to what was judged
RegistryLymphoma, Follicular, once filedthe registry files the study under it
→judged→
On the pageNo longer linkedthe registry no longer files it here

All judgments on this study

WhenLinkJudgeDecisionState
Sep 29The record itselfClinicalTrials.gov recordVersion of 2026-09-29Record change
Oct 1The record itselfClinicalTrials.gov recordVersion of 2026-10-01Record change
Oct 5The record itselfClinicalTrials.gov recordVersion of 2026-10-05Record change
Oct 6The record itselfClinicalTrials.gov recordVersion of 2026-10-06Record change
Oct 7The record itselfClinicalTrials.gov recordVersion of 2026-10-07Record change
Oct 8The record itselfClinicalTrials.gov recordVersion of 2026-10-08Record change
Oct 9The record itselfClinicalTrials.gov recordVersion of 2026-10-09Record change
Oct 13The record itselfClinicalTrials.gov recordVersion of 2026-10-13Record change
Oct 14The record itselfClinicalTrials.gov recordVersion of 2026-10-14Record change
Oct 20The record itselfClinicalTrials.gov recordVersion of 2026-10-20Record change
Oct 21The record itselfClinicalTrials.gov recordVersion of 2026-10-21Record change
Oct 23The record itselfClinicalTrials.gov recordVersion of 2026-10-23Record change
Oct 26The record itselfClinicalTrials.gov recordVersion of 2026-10-26Record change
Oct 28The record itselfClinicalTrials.gov recordVersion of 2026-10-28Record change
Oct 29The record itselfClinicalTrials.gov recordVersion of 2026-10-29Record change
Nov 3The record itselfClinicalTrials.gov recordVersion of 2026-11-03Record change
Nov 9The record itselfClinicalTrials.gov recordVersion of 2026-11-09Record change
Nov 12The record itselfClinicalTrials.gov recordVersion of 2026-11-12Record change
Nov 18The record itselfClinicalTrials.gov recordVersion of 2026-11-18Record change
As of nowLymphoma, FollicularRule based · main-condition ruleMain conditionCurrent
As of nowMosunetuzumabRule based · role ruleTestedCurrent
As of nowRituximabRule based · role ruleTestedCurrent
As of nowRituximab and Hyaluronidase HumanRule based · role ruleTestedCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.